Published in Brain on May 09, 2006
Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol (2013) 3.05
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys. Exp Neurol (2010) 1.47
Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry (2010) 1.42
What brain signals are suitable for feedback control of deep brain stimulation in Parkinson's disease? Ann N Y Acad Sci (2012) 1.31
Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease. Exp Neurol (2007) 1.29
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog Brain Res (2010) 1.23
Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings. J Neurosci (2012) 1.23
Milestones in research on the pathophysiology of Parkinson's disease. Mov Disord (2011) 1.18
Oscillations and the basal ganglia: motor control and beyond. Neuroimage (2013) 1.17
Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. Exp Neurol (2009) 1.14
State-dependent spike and local field synchronization between motor cortex and substantia nigra in hemiparkinsonian rats. J Neurosci (2012) 1.10
Resonance in subthalamo-cortical circuits in Parkinson's disease. Brain (2009) 1.10
Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease? Front Integr Neurosci (2012) 1.08
Effects of dopamine depletion on information flow between the subthalamic nucleus and external globus pallidus. J Neurophysiol (2011) 1.03
Pathological basal ganglia activity in movement disorders. Neuroscience (2011) 1.02
Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements. Brain (2014) 0.92
What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity. Neurobiol Dis (2013) 0.92
The subthalamic nucleus, oscillations, and conflict. Mov Disord (2015) 0.87
Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease. Clin Neurophysiol (2016) 0.87
Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease. J Neurosci (2016) 0.86
Adaptive deep brain stimulation in Parkinson's disease. Parkinsonism Relat Disord (2015) 0.86
Characteristics of the sequence effect in Parkinson's disease. Mov Disord (2010) 0.85
Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network. Front Neurol (2014) 0.84
Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Psychopharmacology (Berl) (2009) 0.84
Mathematical insights into the effects of levodopa. Front Integr Neurosci (2012) 0.83
Past, present, and future of the pathophysiological model of the Basal Ganglia. Front Neuroanat (2011) 0.83
Delta-mediated cross-frequency coupling organizes oscillatory activity across the rat cortico-basal ganglia network. Front Neural Circuits (2013) 0.83
Review: electrophysiology of basal ganglia and cortex in models of Parkinson disease. J Parkinsons Dis (2013) 0.82
The electrocorticogram signal can be modulated with deep brain stimulation of the subthalamic nucleus in the hemiparkinsonian rat. J Neurophysiol (2009) 0.81
Oscillatory Activity in Basal Ganglia and Motor Cortex in an Awake Behaving Rodent Model of Parkinson's Disease. Basal Ganglia (2014) 0.81
Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease. Neurobiol Dis (2015) 0.81
Cognitive factors modulate activity within the human subthalamic nucleus during voluntary movement in Parkinson's disease. J Neurosci (2013) 0.80
Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats. Exp Neurol (2014) 0.80
Involvement of the subthalamic nucleus in engagement with behaviourally relevant stimuli. Eur J Neurosci (2009) 0.79
A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease. Front Pharmacol (2016) 0.78
Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks. J Neurosci (2015) 0.77
A torque-based method demonstrates increased rigidity in Parkinson's disease during low-frequency stimulation. Exp Brain Res (2012) 0.77
Co-modulation of finely tuned high-gamma band activity across hemispheres in Parkinson's disease. Clin Neurophysiol (2013) 0.77
Sixty hertz neurostimulation amplifies subthalamic neural synchrony in Parkinson's disease. PLoS One (2015) 0.76
Frequency-Specific Synchronization in the Bilateral Subthalamic Nuclei Depending on Voluntary Muscle Contraction and Relaxation in Patients with Parkinson's Disease. Front Hum Neurosci (2016) 0.76
Mycobacterium tuberculosis infections in cynomolgus monkey transplant recipients and institution of a screening program for the prevention and control of tuberculosis. BMC Vet Res (2016) 0.75
Understanding and prevention of "therapy-" induced dyskinesias. Parkinsons Dis (2012) 0.75
Technology for deep brain stimulation at a gallop. Mov Disord (2015) 0.75
Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia. Neurobiol Dis (2016) 0.75
Ventral Medial Thalamic Nucleus Promotes Synchronization of Increased High Beta Oscillatory Activity in the Basal Ganglia-Thalamocortical Network of the Hemiparkinsonian Rat. J Neurosci (2016) 0.75
Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia. J Neurophysiol (2016) 0.75
The Parkinsonian Subthalamic Network: Measures of Power, Linear, and Non-linear Synchronization and their Relationship to L-DOPA Treatment and OFF State Motor Severity. Front Hum Neurosci (2016) 0.75
Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias. Exp Brain Res (2016) 0.75
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain (1994) 2.81
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest (1993) 2.79
Manual motor performance in a deafferented man. Brain (1982) 2.63
The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60
Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry (1986) 2.37
Memantine induces reversible neurologic impairment in patients with MS. Neurology (2008) 2.34
Stereotactic targeting of the globus pallidus internus in Parkinson's disease: imaging versus electrophysiological mapping. Neurosurgery (1999) 2.13
Reciprocal inhibition between the muscles of the human forearm. J Physiol (1984) 2.05
Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci (2000) 1.97
Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers. Mov Disord (1997) 1.90
Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. Clin Infect Dis (2008) 1.86
The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain (2001) 1.70
Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry (2009) 1.67
Continuous positive airway pressure as treatment for catathrenia (nocturnal groaning). Neurology (2006) 1.67
The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord (1993) 1.60
Temporal discrimination is abnormal in Parkinson's disease. Brain (1992) 1.59
Echographic findings in infectious endophthalmitis. Arch Ophthalmol (1994) 1.56
Cortical activity preceding self-initiated and externally triggered voluntary movement. Mov Disord (1991) 1.54
Functional modularity of background activities in normal and epileptic brain networks. Phys Rev Lett (2010) 1.54
Echographic evaluation of primary cysts of the iris pigment epithelium. Am J Ophthalmol (1995) 1.51
Dorsal subthalamotomy for Parkinson's disease. Mov Disord (2001) 1.50
The behaviour of the long-latency stretch reflex in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1983) 1.50
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Muscle spasms associated with Sudeck's atrophy after injury. Br Med J (Clin Res Ed) (1984) 1.44
The function of the antagonist muscle during fast limb movements in man. J Physiol (1983) 1.41
Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population. Eur J Neurol (2009) 1.41
Time estimation and reproduction is abnormal in Parkinson's disease. Brain (1992) 1.40
[Motor complications in patients with Parkinson disease treated with levodopa]. Neurologia (1990) 1.38
The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy. Brain (1985) 1.37
Motor response to apomorphine and levodopa in asymmetric Parkinson's disease. J Neurol Neurosurg Psychiatry (1994) 1.36
Myoclonic dystonia. Neurology (1983) 1.34
Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential. J Neurol Neurosurg Psychiatry (1981) 1.33
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J (2007) 1.28
Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol (1998) 1.22
Complex modular structure of large-scale brain networks. Chaos (2009) 1.19
Pathophysiologic basis of surgery for Parkinson's disease. Neurology (2000) 1.19
Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease. Cell Death Dis (2013) 1.17
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain (2005) 1.16
Pathophysiology of dystonias. Adv Neurol (1983) 1.16
Apomorphine infusion for motor fluctuations in Parkinson's disease. Lancet (1987) 1.12
Beta electroencephalograph changes during passive movements: sensory afferences contribute to beta event-related desynchronization in humans. Neurosci Lett (2002) 1.11
Preventing levodopa-induced dyskinesias. Ann Neurol (2000) 1.10
Progressive myoclonic ataxia (the Ramsay Hunt syndrome). Arch Neurol (1990) 1.08
Hemiballism in Parkinson's disease. J Neurol Neurosurg Psychiatry (1995) 1.07
Endoscopic fenestration of a symptomatic cyst of the septum pellucidum. Br J Neurosurg (2000) 1.07
Cabergoline in Parkinson's disease: long-term follow-up. Neurology (1993) 1.07
Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience (1997) 1.07
Movement-related changes in oscillatory activity in the human subthalamic nucleus: ipsilateral vs. contralateral movements. Eur J Neurosci (2005) 1.07
Adrenoleukomyeloneuropathy presenting as spinocerebellar degeneration. Neurology (1982) 1.07
Hemi-dystonia secondary to localised basal ganglia tumour. J Neurol Neurosurg Psychiatry (1984) 1.06
On the significance of giant somatosensory evoked potentials in cortical myoclonus. J Neurol Neurosurg Psychiatry (1984) 1.05
Advantages of binaural hearing provided through bimodal stimulation via a cochlear implant and a conventional hearing aid: a 6-month comparative study. Acta Otolaryngol (2005) 1.05
Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry (2004) 1.04
Changes in subthalamic activity during movement observation in Parkinson's disease: is the mirror system mirrored in the basal ganglia? Clin Neurophysiol (2009) 1.03
Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease. Lancet (1986) 1.02
Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res (1997) 1.01
Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain (1996) 1.00
Performance of repetitive wrist movements in Parkinson's disease. Brain (1992) 1.00
Aggravation of Parkinson's disease by cinnarizine. J Neurol Neurosurg Psychiatry (1987) 1.00
Quality of life of caregivers in Parkinson's disease. Qual Life Res (2005) 0.99
The blink reflex in patients with idiopathic torsion dystonia. Arch Neurol (1990) 0.99
Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology (1989) 0.98
Spontaneous separation in idiopathic vitreomacular traction syndrome associated with contralateral full-thickness macular hole. Eur J Ophthalmol (2006) 0.98
Cerebral arteriovenous malformations. Comparative results of surgical vs conservative treatment in 112 cases. J Neurosurg Sci (1984) 0.98
What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson's disease. Exp Neurol (2009) 0.97
Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurology (2000) 0.97
Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology (2000) 0.97